PROPEL

New PROPEL Survey Feature

August 11, 2023 by

In the fast-paced world of clinical trials, feasibility surveys have become a crucial step in the process. These surveys help researchers determine the viability of their trials and ensure that all the necessary resources and capabilities are in place. However, it is important to recognize that surveys have the potential to be powerful tools in various other aspects of clinical research. Building relationships, understanding site capabilities, and gathering feedback are just a few of the areas where surveys can prove to be invaluable. 

Surveys are an incredibly powerful tool, allowing researchers to collect feedback and insights from a wide range of recipients. Whether it’s gathering information from sites within your network, potential vendors, patients, or investigators, surveys can provide valuable data that can inform important decisions. 

PROPEL Enterprise’s new Survey Feature is an exciting development for the clinical trial industry. With this innovative tool, researchers can create and distribute surveys directly within the platform, reaching a large audience and gaining valuable data in a streamlined and efficient manner. 

How It Works 

PROPEL Enterprise‘s new Survey Feature functionality (GIF). 

Quickly create and send surveys directly within PROPEL to LYNK users or external email lists. Use pre-built templates, import existing questions, or create a survey from scratch with PROPEL’s easy-to-use interface. For ease of tracking, you can also associate your survey with a specific trial, contact, or account. 

Once a survey is sent, PROPEL will automatically collect all timing and response data in one place for easy monitoring and reporting – giving you real-time visibility into who has completed a survey, who hasn’t, and who stopped part-way through. But the feature doesn’t stop there – eliminate endless follow-up emails with automated alerts and reminders. 

Instead of relying on multiple programs and websites to send and track surveys, PROPEL provides a closed-loop system allowing you to make surveys, send them out, and to get in-depth analytics on responses and timing.  

For Any Kind of Survey 

Survey Feature interface. 

PROPEL’s new feature aims to transform and streamline the survey process – from feasibility and CSAT to PI onboarding, equipment management, and beyond! Surveys can be as general or specific as you want and for any use case under the sun. Want to know what kind of studies sites are looking for? Need to follow-up with a site or PI about a recent onboarding? PROPEL’s new Survey Feature is here to help! 

Ready to see how Devana Solutions continues to revolutionize how clinical research professionals gather and analyze feedback? Schedule a demo today! 

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

PROPEL

PROPEL Spring ’23 Update

May 26, 2023 by

Get ready for an exhilarating update to PROPEL! The Spring ’23 Update brings a plethora of enhancements, refinements, and additions to the platform designed to improve and streamline the user experience system wide with a heavy focus on Trials and Trial Management.  

PROPEL’s latest release is all about optimizing glanceability and improving workflows while prioritizing the information that means the most, from harmonized field names to a new glossary for credentials and the release of Trialstones. The theme underlining the entire release can be summed up as “Trials” – which have been given a complete makeover, including new Trialstones, streamlined tabs and fields, and a progress bar to keep track of trial status. 

What’s New? 

The user interface (UI) has been updated and enhanced across several areas of the platform so everything can be quickly absorbed at a glance. A key part of the updated UI is the new progress bar, which clearly shows what stage a trial is currently in. New, more visually compelling monitoring tiles have replaced checklists in various places, making content more scannable and insights digestible. See below for a look at the new real-time progress bar and pre-award Trialstones tiles.  

PROPEL Trial page with new progress bar and pre-award Trialstones.

What’s a Trialstone, you ask? Pre- and post-award trial milestones are now known as Trialstones throughout the platform. When sites complete Trialstones such as CDA Executed or PSV Complete, this information will be updated across the system – including advancing the trial stage in the new progress bar. Users can track and manage Trialstones directly from any trial page within PROPEL for improved workflows. With the new update, Trialstones can also be updated for multiple sites at once to save time.  

Another great new feature coming in this update is that trials can now be marked as high priority. Making a trial high priority adds a red star to the list view, clearly calling out trials which have been flagged. This new feature allows central team users to delineate which opportunities and trials sites should focus on first. 

We’ve only covered some of the broader highlights, but the Spring 2023 Update brings a lot of exciting new quality of life changes to PROPEL and LYNK. Full release notes and training materials have already been made available to our existing partner-clients. If you’re interested in learning more, please contact us today and we’d be happy to give you a demo of our game-changing platform. 

Devana’s product development pipeline has more exciting updates and features coming soon, so stay tuned!  

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

Clinical Trials | PROPEL

Effectively Manage Decentralized Sites with Clinical Trial Software

June 23, 2022 by

Since the beginning of the COVID-19 pandemic, more and more organizations have been exploring the possibilities of decentralized clinical trials (DCTs). Decentralized trials have many benefits, including accelerated patient access, improved patient engagement and retention, and increased diversity. Unfortunately, these benefits also come with challenges such as reduced collaboration and limited data access.

Clinical trial software such as Devana Solutions PROPEL can help central research operations connect to decentralized site staff during study startup through trial completion, regardless of site location.

Increase Collaboration, Data-Sharing, and Visibility Across DCTs

Devana Solution’s cloud-based software seamlessly and securely connects central research sites, CROs, Sponsors, and decentralized sites, facilitating real-time collaboration and sharing of data. Our solutions allow research operations professionals to share protocols, contracts, budgets, and other supporting trial documentation with decentralized sites, speeding study startup and improving visibility across the trial’s network.

Forget managing cumbersome emails, phone calls, and lengthy meetings—central teams can communicate directly to sites within PROPEL, and all correspondence is logged for future reference. Sites can also update their key milestones via our LYNK interface, ensuring the central team is always aware of the status of the trial. Central research teams can even assign tasks to sites and view what has been completed and remains outstanding.

Instead of manually searching for opportunities or site-specific details, PROPEL allows users to query all sites, filter key data, and collate opportunities. Customizable dashboards and reports provide real-time visibility and help centralized and site-based decision-makers gain actionable insights. The Devana Solutions platform can connect every functional group in a network’s entire organization, from business development and regulatory to finance and leadership.

By leveraging the cloud to connect central teams with site-based clinicians and staff for real-time collaboration, PROPEL provides easy access and visibility to trial, site, user, and contact data across your network—helping to bridge data gaps, secure more trial opportunities, hit more targets, and win more awards.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Our platform bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trial systems.

Let us show you in more detail what Better Data, Better Decisions, and Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Events | Partner Spotlight

Devana Solutions Joins Global Leader in Blood Cancer Fight

February 8, 2022 by

Devana Solutions is proud to announce their sponsorship of the Leukemia & Lymphoma Society's Students of the Year program and Grace and Jack Sherner’s Raise Hope Together team.Devana Solutions is proud to announce their sponsorship of Team Raise Hope Together, formed by Grace and Jack Sherner, as part of the Leukemia & Lymphoma Society Students of the Year program. Students of the Year is a philanthropic leadership development program for exemplary high school students that fosters professional skills such as entrepreneurship, marketing, and project management. The students involved in this campaign raise funds for The Leukemia & Lymphoma Society, the world’s largest nonprofit fighting blood cancer.

The Sherners, along with their friend Theo Weiman, formed Team Raise Hope Together in honor of their children’s grandfather, Larry Thayer, who was diagnosed with CLL (Chronic Lymphocytic Leukemia) in 2007.

In April of this past year, their children’s aunt, Betsy, found a tumor on her left breast. Days later, she received a breast cancer diagnosis. In the months since, she has undergone a double mastectomy and a complete hysterectomy.

Devana Solutions is joining to be a part of the generation that puts an end to cancer and provides a monumental impact in the fight.

Devana Solutions’ CEO and Co-founder Barry Lake comments on the effort, “We are proud to support Leukemia & Lymphoma Society and the Students of the Year program. We strive to offer solutions to those committed to the fight against cancer, helping those researchers on the frontline close the gap in eliminating cancer by cutting time and costs in the drug development process. One day, we will defeat cancer!”

The Leukemia & Lymphoma Society is on a mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma and improve the quality of life for patients and their families. Since 1949, the Leukemia & Lymphoma Society has invested more than $1.5 billion in research to advance therapies and save lives. Today, blood cancer patients live longer because of these advancements made possible by the Leukemia & Lymphoma Society.

The family remains committed to defeating their diagnoses. “I continue to work on my personal recovery, which requires piecing together a new body, mind, and spirit,” their Aunt Betty said.

Join Devana Solutions before March 12 with your donation to Team Raise Hope Together.